Status:
COMPLETED
Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients
Lead Sponsor:
University of Chicago
Conditions:
Heart Failure
Heart Assist Device
Eligibility:
All Genders
18+ years
Brief Summary
This research study will compare two standard of care approaches for managing low sodium levels in heart failure patients with Left Ventricular Assist Device (LVAD). The study will compare the outcome...
Eligibility Criteria
Inclusion
- Hospitalized patients with American College of Cardiology (ACC) and the American Heart Association (AHA) Stage D heart failure and plan to undergo LVAD implantation
- Age greater than or equal to 18 years old
Exclusion
- No plan for LVAD implantation
- Age less than 18 years old
Key Trial Info
Start Date :
March 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05408104
Start Date
March 28 2019
End Date
May 1 2022
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medical Center
Chicago, Illinois, United States, 60637